Bartosz Hudzik: Clarifying Pulmonary Embolism Care with the New AHA/ACC Guideline
Bartosz Hudzik, Editorial Consultant at JACC Case Reports, shared a post on LinkedIn about the new AHA/ACC guideline by Mark A. Creager et al, adding:
”Pulmonary embolism care is evolving — and the new AHA/ACC guideline makes that clear.
This isn’t just another update.
It reflects a broader shift from treating PE as a single acute event to managing it as a risk-stratified clinical pathway with structured follow-up.
A few takeaways that stand out:
- Risk stratification is now central to decision-making. The new classification framework helps identify which patients truly need intensive intervention — and which may be safely managed with less resource-intensive pathways.
- Therapeutic strategy continues to modernize. Direct oral anticoagulants remain preferred for most eligible patients, reinforcing the move toward safer, more streamlined anticoagulation.
- Follow-up is part of treatment. Persistent symptoms, functional limitation, and chronic thromboembolic disease are now explicitly addressed — highlighting that PE outcomes are determined long after discharge.
For clinicians, this means re-thinking workflows and escalation pathways.
For hospitals, it strengthens the case for coordinated PE response teams.
For patients, it signals more individualized and longitudinal care.
Curious how others are translating these recommendations into practice — particularly around triage pathways, outpatient management, and structured follow-up.
Cardiology and thrombosis experts across academia and clinical practice — would value your perspective on implementation challenges and opportunities”
Title: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Authors: Mark A. Creager, Geoffrey D. Barnes, Jay Giri, Debabrata Mukherjee, William Schuyler Jones, Allison E. Burnett, Teresa Carman, Ana I. Casanegra, Lana A. Castellucci, Sherrell M. Clark, Mary Cushman, Kerstin de Wit, Jennifer M. Eaves, Margaret C. Fang, Joshua B. Goldberg, Stanislav Henkin, Hillary Johnston-Cox, Sabeeda Kadavath, Daniella Kadian-Dodov, William Brent Keeling, Andrew J. P. Klein, Jun Li, Michael C. McDaniel, Lisa K. Moores, Gregory Piazza, Karen S. Prenger, Steven C. Pugliese, Mona Ranade, Rachel P. Rosovsky, Farla Russo, Eric A. Secemsky, Akhilesh K. Sista, Leben Tefera, Ido Weinberg, Lauren M. Westafer, Michael N. Young
Read the Full Article on Circulation
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 21, 2026, 12:12Agata Grochowska: Thromboprophylaxis and Coagulation Challenges in Pancreatic Cancer
-
Feb 21, 2026, 12:08John Chuback: Recognizing the Early Warning Signs of DVT
-
Feb 21, 2026, 11:44Pedro Perez: This New PE Guideline Gives Practical Clues on Risk, Evaluation, and Care Pathways
-
Feb 21, 2026, 11:05Tagreed Alkaltham: When Blood Banks Say NO and Save a Life
-
Feb 21, 2026, 10:49Sheharyar Raza: The Leaky Pipeline of AI and Machine Learning in Transfusion Medicine
-
Feb 20, 2026, 17:35Wolfgang Miesbach: Plasma FIX Is Only Part of the Story In Haemophilia B
-
Feb 20, 2026, 17:27Sheharyar Raza: Examining Guideline Discordance in Evidence-Based Apheresis Recommendations
-
Feb 20, 2026, 17:23Barbara Mora: Newly Discovered EPO Gene Intronic Variant as a Cause of Congenital Erythrocytosis
-
Feb 20, 2026, 16:48Miguel Brito: Newborn Screening and Challenges in Follow-Up Care for Sickle Cell Disease in Angola